Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20029394HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS20030211HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS20029395HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS20030515HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS20030212HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS20030516HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS20029396HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS20030213HPVENSG00000105675.9protein_codingATP4ANoNo495P20648
TVIS44027647HTLV-1ENSG00000105675.9protein_codingATP4ANoNo495P20648
TCGA Plot Options
Drug Information
GeneATP4A
DrugBank IDDB00448
Drug NameLansoprazole
Target IDBE0000349
UniProt IDP20648
Regulation Typeinhibitor
PubMed IDs11693467; 9279507; 11752352
CitationsMatheson AJ, Jarvis B: Lansoprazole: an update of its place in the management of acid-related disorders. Drugs. 2001;61(12):1801-33.@@Langtry HD, Wilde MI: Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders. Drugs. 1997 Sep;54(3):473-500.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved; Investigational
Direct ClassificationSulfinylbenzimidazoles
SMILESCC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1
PathwaysLansoprazole Metabolism Pathway; Lansoprazole Action Pathway
PharmGKBPA450180
ChEMBLCHEMBL480